Matt Chrysler, MBA

Matt Chrysler is Head of Portfolio & Alliance Management at TRexBio. He joined TRexBio with 15 years of portfolio and commercial experience in both emerging and large biotechnology companies. Most recently, he led New Product Planning at Ultragenyx, driving early-stage pipeline strategy decisions for potential gene therapy, biologic and small molecule therapeutics. Previously at Ultragenyx he was Global Commercial Lead for multiple late-stage programs, including overseeing launch preparations for Crysvita in collaboration with a global pharmaceutical partner. Earlier in his career, he held a variety of portfolio management, corporate strategy and brand management roles at Genentech. He started his career as a Management Consultant at ZS Associates.

Mr. Chrysler earned an MBA and MS in biochemistry from Georgetown University and a BS in microbiology from the University of Washington.